Science Pool

Evotec and Takeda enter strategic RNA targeting drug discovery and development alliance

Evotec SE today announced that the Company has entered into a multi-RNA target alliance with Takeda Pharmaceutical Company Limited (“Takeda”) with the goal to discover and develop RNA targeting small molecule therapeutics for highly attractive targets that are difficult to address via more conventional approaches.
Read More

Twitter
LinkedIn
Email